,i #aafth ,,congress #b;d ,session ,h4 ,r4 #fagh ,,in ,,the ,,house ,,of ,,representatives ,march #aj1 #bjbj,ms4 ,bonamici 7for herself1 ,mr4 ,nadler1 ,mr4 ,grijalva1 ,mr4 ,blumenauer1 and ,mr4 ,sablan7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,public ,health ,service ,act to provide for a demonstration program to facilitate the clinical adoption of pregnancy intention screening initiatives by health care and social service providers4 #a4 ,short title ,this ,act may be cited as the ,enhancing ,questions to ,understand ,intentions for ,pregnancy ,act of #bjbj or the ,,equip ,act of #bjbj4 #b4 ,pregnancy intention screening initiative demonstration program ,part ,p of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhj;g et seq47 is amended by adding at the end the following new section3 #cii,v-#g4 ,pregnancy intention screening initiative demonstration program 7a7 ,program establishment ,the ,secretary1 through the ,director of the ,centers for ,disease ,control and ,prevention1 shall establish a demonstration program to facilitate the clinical adoption of pregnancy intention screening initiatives by health care and social service providers4 7b7 ,grants ,the ,secretary may carry out the demonstration program through awarding grants to eligible entities to implement pregnancy intention screening initiatives1 collect data1 and evaluate such initiatives4 7c7 ,eligible ,entities 7#a7 ,in general ,an eligible entity under this section is an entity described in paragraph 7#b7 that provides non-directive1 comprehensive1 medically accurate information4 7#b7 ,entities described ,for purposes of paragraph 7#a71 an entity described in this paragraph is a community-based organization1 voluntary health organization1 public health department1 community health center1 or other interested public or private primary1 behavioral1 or other health care or social service provider or organization4 7d7 ,pregnancy intention screening initiative ,for purposes of this section1 the term pregnancy intention screening initiative means any initiative by an eligible entity to routinely screen women with respect to their pregnancy desires and goals to either prevent unintended pregnancies or improve the likelihood of healthy pregnancies1 in order to better provide health care that meets the contraceptive or pre-pregnancy needs and goals of such women4 7e7 ,evaluation 7#a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 shall1 by grant or contract1 and after consultation as described in paragraph 7#b71 conduct an evaluation of the demonstration program1 with respect to pregnancy intention screening initiatives1 conducted under this section4 ,such an evaluation shall include3 7,a7 ,assessment of the implementation of pregnancy intention screening protocols among a diverse group of patients and providers1 including collecting data on the experiences and outcomes for diverse patient populations in a variety of clinical settings4 7,b7 ,analysis of outcome measures that will facilitate effective and widespread adoption of such protocols by health care providers for inquiring about and responding to pregnancy goals of women with both contraceptive and pre-pregnancy care4 7,c7 ,consideration of health disparities among the population served4 7,d7 ,assessment of the equitable and voluntary application of such initiatives to minority and medically underserved communities4 7,e7 ,assessment of the training1 capacity1 and ongoing technical assistance needed for providers to effectively implement such pregnancy intention screening protocols4 7,f7 ,assessment of whether referral systems for selected protocols follow evidence-based standards that ensure access to comprehensive health services and appropriate follow-up care4 7,g7 ,measuring through rigorous methods the effect of such initiatives on key health outcomes4 7#b7 ,consultation with independent experts ,in conducting any evaluation under paragraph 7#a71 the ,director of the ,centers for ,disease ,control and ,prevention shall consult with physicians1 physician assistants1 advanced practice registered nurses1 registered nurses1 nurse midwives1 and other health care providers who specialize in women's health1 and other experts in public health1 clinical practice1 program evaluation1 and research4 7#c7 ,report ,not later than one year after the last day of the demonstration program under this section1 the ,director of the ,centers for ,disease ,control and ,prevention shall submit to ,congress a report on the results of the evaluation conducted under paragraph 7#a7 and shall make the report publicly available4 7f7 ,funding 7#a7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #aj1jjj1jjj for each of fiscal years #bjba through #bjbc4 7#b7 ,limitation ,not more than #bj percent of funds appropriated to carry out this section pursuant to paragraph 7#a7 for a fiscal year may be used for purposes of the evaluation under subsection 7e74 4